vs

Side-by-side financial comparison of Confluent, Inc. (CFLT) and CLOVER HEALTH INVESTMENTS, CORP. (CLOV). Click either name above to swap in a different company.

CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($749.2M vs $314.8M, roughly 2.4× Confluent, Inc.). CLOVER HEALTH INVESTMENTS, CORP. runs the higher net margin — 3.6% vs -25.2%, a 28.8% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (62.0% vs 20.5%). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (45.0% CAGR vs 20.4%).

Confluent, Inc. is an American technology company headquartered in Mountain View, California. Confluent was founded by Jay Kreps, Jun Rao and Neha Narkhede on September 23, 2014, in order to commercialize an open-source streaming platform Apache Kafka, created by the same founders while working at LinkedIn in 2008 as a B2B infrastructure company. Confluent's products are the Confluent Cloud, Confluent Platform, Connectors, Apache Flink, Stream Governance and Confluent Hub.

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

CFLT vs CLOV — Head-to-Head

Bigger by revenue
CLOV
CLOV
2.4× larger
CLOV
$749.2M
$314.8M
CFLT
Growing faster (revenue YoY)
CLOV
CLOV
+41.5% gap
CLOV
62.0%
20.5%
CFLT
Higher net margin
CLOV
CLOV
28.8% more per $
CLOV
3.6%
-25.2%
CFLT
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
45.0%
20.4%
CFLT

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CFLT
CFLT
CLOV
CLOV
Revenue
$314.8M
$749.2M
Net Profit
$-79.2M
$27.3M
Gross Margin
74.7%
Operating Margin
-31.5%
3.6%
Net Margin
-25.2%
3.6%
Revenue YoY
20.5%
62.0%
Net Profit YoY
10.0%
EPS (diluted)
$-0.23
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CFLT
CFLT
CLOV
CLOV
Q1 26
$749.2M
Q4 25
$314.8M
$487.7M
Q3 25
$298.5M
$496.6M
Q2 25
$282.3M
$477.6M
Q1 25
$271.1M
$462.3M
Q4 24
$261.2M
$337.0M
Q3 24
$250.2M
$331.0M
Q2 24
$235.0M
$356.3M
Net Profit
CFLT
CFLT
CLOV
CLOV
Q1 26
$27.3M
Q4 25
$-79.2M
$-49.3M
Q3 25
$-66.5M
$-24.4M
Q2 25
$-82.0M
$-10.6M
Q1 25
$-67.6M
$-1.3M
Q4 24
$-88.1M
$-22.1M
Q3 24
$-74.1M
$-9.2M
Q2 24
$-89.9M
$7.4M
Gross Margin
CFLT
CFLT
CLOV
CLOV
Q1 26
Q4 25
74.7%
Q3 25
74.2%
Q2 25
73.7%
Q1 25
74.5%
Q4 24
74.1%
Q3 24
74.5%
24.5%
Q2 24
72.3%
30.3%
Operating Margin
CFLT
CFLT
CLOV
CLOV
Q1 26
3.6%
Q4 25
-31.5%
-10.1%
Q3 25
-27.9%
-4.9%
Q2 25
-34.2%
-2.2%
Q1 25
-37.3%
-0.3%
Q4 24
-40.5%
-6.4%
Q3 24
-37.4%
-2.7%
Q2 24
-46.1%
2.0%
Net Margin
CFLT
CFLT
CLOV
CLOV
Q1 26
3.6%
Q4 25
-25.2%
-10.1%
Q3 25
-22.3%
-4.9%
Q2 25
-29.0%
-2.2%
Q1 25
-24.9%
-0.3%
Q4 24
-33.7%
-6.6%
Q3 24
-29.6%
-2.8%
Q2 24
-38.3%
2.1%
EPS (diluted)
CFLT
CFLT
CLOV
CLOV
Q1 26
$0.05
Q4 25
$-0.23
Q3 25
$-0.19
Q2 25
$-0.24
Q1 25
$-0.20
Q4 24
$-0.26
Q3 24
$-0.23
Q2 24
$-0.28

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CFLT
CFLT
CLOV
CLOV
Cash + ST InvestmentsLiquidity on hand
$347.2M
$177.6M
Total DebtLower is stronger
$1.1B
Stockholders' EquityBook value
$1.2B
$339.4M
Total Assets
$3.0B
$697.7M
Debt / EquityLower = less leverage
0.94×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CFLT
CFLT
CLOV
CLOV
Q1 26
$177.6M
Q4 25
$347.2M
$78.3M
Q3 25
$298.5M
Q2 25
$295.6M
Q1 25
$278.6M
Q4 24
$386.0M
$194.5M
Q3 24
$322.6M
$288.0M
Q2 24
$311.3M
$254.8M
Total Debt
CFLT
CFLT
CLOV
CLOV
Q1 26
Q4 25
$1.1B
Q3 25
$1.1B
Q2 25
$1.1B
Q1 25
$1.1B
Q4 24
$1.1B
Q3 24
$1.1B
Q2 24
$1.1B
Stockholders' Equity
CFLT
CFLT
CLOV
CLOV
Q1 26
$339.4M
Q4 25
$1.2B
$308.7M
Q3 25
$1.1B
$340.9M
Q2 25
$1.1B
$344.2M
Q1 25
$1.0B
$336.1M
Q4 24
$961.2M
$341.1M
Q3 24
$934.3M
$342.2M
Q2 24
$873.9M
$324.9M
Total Assets
CFLT
CFLT
CLOV
CLOV
Q1 26
$697.7M
Q4 25
$3.0B
$541.0M
Q3 25
$2.9B
$559.7M
Q2 25
$2.8B
$575.0M
Q1 25
$2.7B
$583.7M
Q4 24
$2.7B
$580.7M
Q3 24
$2.6B
$653.0M
Q2 24
$2.5B
$674.2M
Debt / Equity
CFLT
CFLT
CLOV
CLOV
Q1 26
Q4 25
0.94×
Q3 25
0.98×
Q2 25
1.03×
Q1 25
1.07×
Q4 24
1.14×
Q3 24
1.17×
Q2 24
1.25×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CFLT
CFLT
CLOV
CLOV
Operating Cash FlowLast quarter
$42.1M
Free Cash FlowOCF − Capex
$41.7M
FCF MarginFCF / Revenue
13.2%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$60.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CFLT
CFLT
CLOV
CLOV
Q1 26
Q4 25
$42.1M
$-66.9M
Q3 25
$30.8M
$12.1M
Q2 25
$18.1M
$5.4M
Q1 25
$-26.8M
$-16.3M
Q4 24
$35.2M
$34.8M
Q3 24
$15.6M
$50.0M
Q2 24
$8.6M
$44.8M
Free Cash Flow
CFLT
CFLT
CLOV
CLOV
Q1 26
Q4 25
$41.7M
$-69.0M
Q3 25
$30.0M
$11.4M
Q2 25
$17.2M
$4.8M
Q1 25
$-28.2M
$-16.5M
Q4 24
$34.5M
$33.3M
Q3 24
$15.0M
$49.6M
Q2 24
$7.5M
$44.4M
FCF Margin
CFLT
CFLT
CLOV
CLOV
Q1 26
Q4 25
13.2%
-14.1%
Q3 25
10.0%
2.3%
Q2 25
6.1%
1.0%
Q1 25
-10.4%
-3.6%
Q4 24
13.2%
9.9%
Q3 24
6.0%
15.0%
Q2 24
3.2%
12.5%
Capex Intensity
CFLT
CFLT
CLOV
CLOV
Q1 26
Q4 25
0.1%
0.4%
Q3 25
0.3%
0.1%
Q2 25
0.3%
0.1%
Q1 25
0.5%
0.0%
Q4 24
0.3%
0.5%
Q3 24
0.2%
0.1%
Q2 24
0.5%
0.1%
Cash Conversion
CFLT
CFLT
CLOV
CLOV
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
6.04×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CFLT
CFLT

Confluent Cloud$169.4M54%
Post Contract Customer Support$93.8M30%
License$38.4M12%
Services$13.2M4%

CLOV
CLOV

Segment breakdown not available.

Related Comparisons